Vimarsana
Biggest News Aggregation in the World

Rupinder Singh News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rupinder Singh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rupinder Singh Today - Breaking & Trending Today

BBCNEWS BBC Newsroom Live February 27, 2020 11:00:00 - Vimarsana News

BBCNEWS BBC Newsroom Live February 27, 2020 11:00:00

Youre watching bbc newsroom live its11am and these are the main stories this morning. A major blow for plans for a third runway at heathrow the court of appeal rules it unlawful as a result of the uks climate commitments. Two more people in the uk test positive for coronavirus bringing the total number of cases here to 15. With more than a0 countries now infected with coronavirus, saudi arabia stops pilgrims from entering the country over fears about the spread of the virus President Trump tries to calm fears in the us, telling his country the risk remains very low. Hes put Vice President mike...

Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds - Vimarsana News

Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds

A study by Stanford University researchers found that a 15-day course of Pfizer's Paxlovid did not relieve symptoms of long COVID among 155 participants.

15-day Paxlovid regimen safe but adds no clear long-COVID benefit - Vimarsana News

15-day Paxlovid regimen safe but adds no clear long-COVID benefit

A clinical trial led by Stanford Medicine researchers has found that a 15-day course of Paxlovid, an antiviral drug targeting the virus that causes

Extended Course of Paxlovid Adds No Benefit for Those With Long COVID - Vimarsana News

Extended Course of Paxlovid Adds No Benefit for Those With Long COVID

Key Takeaways

Paxlovid Fails First Test in Long COVID - Vimarsana News

Paxlovid Fails First Test in Long COVID

Trial had been stopped early for lack of efficacy